Leprosy Resurgence Sends Public Health Concern
February 27, 2024
KEMRI’s New HIV/AIDS Vaccine Drive
March 7, 2024
Leprosy Resurgence Sends Public Health Concern
February 27, 2024
KEMRI’s New HIV/AIDS Vaccine Drive
March 7, 2024

KEMRI Strategic Plan 2023-28 Stakeholders Engagement Platform

Kenya Medical Research Institute (KEMRI) is a State Corporation established in 1979 as national body responsible for carrying out research for human health in Kenya. Within the health sector, KEMRI has continued to provide leadership in research & development, shape national health research agenda, promote evidence- based policy formulation, monitor, and assess health trends as well as dealing with trans-boundary health threats and disease outbreaks. In order to effectively execute its mandate, KEMRI has developed Strategic Plan 2023 – 2028 which will lay a firm foundation for development of innovative research products that will support realization of Universal Health Coverage (UHC).

Access the draft strategic plan here: https://www.kemri.go.ke/wp-content/uploads/2024/02/Final-Draft.-KEMRI-SP-2023-28-Stakeholders-1.pdf

Internal and external stakeholders are hereby invited to review the attached draft KEMRI Strategic plan 2023-28 and give their input using google form which can be accessed through the following link: https://docs.google.com/forms/d/1OdPCS6BgnAc4FGAxEogty9RjXfaliQXeHmgXynK2Acc/edit

Skip to content